Neonatal sepsis remains a feared and serious complication, especially among very low birth
weight (VLBW) preterm infants. Neonatal sepsis is divided into early-onset and late-onset …

This review compares the pharmacology, spectrum of antifungal activity, pharmacokinetic
and pharmacodynamic properties, safety and clinical efficacy of the three licensed …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Guidelines for the management of patients with invasive candidiasis and mucosal
candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America …

Clin Microbiol Infect 2012; 18 (Suppl. 7): 38–52 Abstract Invasive candidiasis (IC) is a
relatively common syndrome in neonates and children and is associated with significant …

Scope Presenting symptoms, distributions and patterns of diseases and vulnerability to
invasive aspergillosis (IA) are similar between children and adults. However, differences …

It has been nearly a decade since caspofungin was approved for clinical use as the first
echinocandin class antifungal agent, followed by micafungin and anidulafungin. The …

This report updates and combines into one document earlier versions of guidelines for
preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected …

Objective: To review the mechanism of action, antifungal spectrum of activity,
pharmacodynamics, pharmacokinetics, clinical efficacy, and safety of the echinocandins …

Background: Invasive candidiasis is increasingly prevalent in premature infants and
seriously ill children, and pediatric data on available antifungal therapies are lacking …